EPISODE #149 Project Twenty21 Update with Anne Katrin Schlag and Mags Houston from Drug Science
This week we’re excited to welcome Mags Houston and Dr. Anne Katrin Schlag from Drug Science - independent science led drugs charity based in London.
Together, we explore how ProjectTwenty21 is progressing, some of the initial findings from the participating patient set, alongside digging into the true value of real-world data as a form of medical evidence opposed to randomised controlled trials.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at www.luminorecruit.com/
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e149
About Dr Anne Katrin Schlag - Head of Research at Drug Science
Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science (https://drugscience.org.uk). She leads the research for the Drug Science Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.
She holds Honorary Fellowships at both Imperial College London and King’s College London, chairs the research subgroup of the Cannabis Industry Council, and is scientific advisor to the Primary Care Cannabis Network.
About Mags Houston - Head of T21 at Drug Science
As Head of Project Twenty21, Mags is the operational lead for Drug Science’s medical cannabis observational study, helping to raise awareness amongst patients and prescribers, build more evidence by attracting more patients and prescribers to actively join the project, and educate the public about the growing evidence surrounding medical cannabis for treating a range of conditions. Alongside her role on T21, she volunteers for Heroic Hearts Project UK, a not-for-profit that helps veterans suffering with PTSD by providing retreats and education in psychedelic therapy. She also curates and hosts events for The Psychedelic Society (UK) around drug policy, psychedelic science and mental health treatment. Mags’ mission is to shift the mainstream narrative around drugs by helping to provide education and challenging UK drug policy, so that therapies and medicines that are currently not accessible to patients might be made available on the NHS and prescribed to the people who desperately need them.
Resources
Drug Science’s Website: https://www.drugscience.org.uk
Project Twenty21: https://www.drugscience.org.uk/project-twenty-21/
Join Anne on LinkedIn: https://www.linkedin.com/in/anne-katrin-schlag-3886a4/
Join Mags on LinkedIn: https://www.linkedin.com/in/ACoAAAOCG4IBadL6I3LJNez4_WtaJaWoemfjZlQ/
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
The cannabis industry is gaining traction across the world, as new medical discoveries, and multi-billion dollar businesses are grabbing the headlines on a regular basis. Experts predict the worldwide industry could be worth in excess of $300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about. I want to find out more about what's happening, and I'm bringing you along for the ride. Join me - Anuj Desai - as I speak to a wide variety of guests who are helping to shape this nascent sector. Having interviewed over 100 guests, including patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business.
Where can you listen?
